NO20034145L - Fremgangsmåte til å produsere en vaksine - Google Patents

Fremgangsmåte til å produsere en vaksine

Info

Publication number: NO20034145L
Authority: NO; Norway
Prior art keywords: vaccine; procedure; producing
Prior art date: 2001-03-23

Application number

NO20034145A

Other languages

English (en)

Other versions

NO20034145D0 (no

Inventor

Hans Loibner

Helmut Eckert

Otto Dobblohoff-Dier

Ralf Kircheis

Manfred Schuster

Erich Wasserbauer

Guenter Waxenecker

Gottfried Himmler

Original Assignee

Igeneon Krebs Immuntherapie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-23

Filing date

2003-09-17

Publication date

2003-11-07

2003-09-17 Application filed by Igeneon Krebs Immuntherapie filed Critical Igeneon Krebs Immuntherapie

2003-09-17 Publication of NO20034145D0 publication Critical patent/NO20034145D0/no

2003-11-07 Publication of NO20034145L publication Critical patent/NO20034145L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Neurology (AREA)
Endocrinology (AREA)
Communicable Diseases (AREA)
Emergency Medicine (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Obesity (AREA)
Hematology (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Reproductive Health (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20034145A 2001-03-23 2003-09-17 Fremgangsmåte til å produsere en vaksine NO20034145L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0047001A AT410636B (de)	2001-03-23	2001-03-23	Verfahren zur herstellung eines impfstoffes
PCT/AT2002/000091 WO2002080966A2 (de)	2001-03-23	2002-03-20	Verfahren zur herstellung eines autologen antikörpers enthaltenden impfstoffes

Publications (2)

Publication Number	Publication Date
NO20034145D0 NO20034145D0 (no)	2003-09-17
NO20034145L true NO20034145L (no)	2003-11-07

Family

ID=3674741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034145A NO20034145L (no)	2001-03-23	2003-09-17	Fremgangsmåte til å produsere en vaksine

Country Status (13)

Country	Link
US (1)	US20040191242A1 (no)
EP (1)	EP1370289A2 (no)
JP (1)	JP2004524369A (no)
CN (1)	CN1522155A (no)
AT (1)	AT410636B (no)
BR (1)	BR0208641A (no)
CA (1)	CA2441499A1 (no)
HU (1)	HUP0303638A3 (no)
MX (1)	MXPA03008587A (no)
NO (1)	NO20034145L (no)
PL (1)	PL363720A1 (no)
SK (1)	SK11732003A3 (no)
WO (1)	WO2002080966A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT410637B (de) *	2001-06-01	2003-06-25	Igeneon Krebs Immuntherapie	Verwendung von polyklonalen immunglobulinen
WO2005090403A2 (en) *	2004-03-12	2005-09-29	Biovest International, Inc.	Method and apparatus for antibody purification
JP5415963B2 (ja) *	2007-02-21	2014-02-12	オスロユニベルシテートシケヒュースホーエフ	新しい癌マーカー
EP2236520A1 (en)	2009-03-31	2010-10-06	Leukocare Ag	Stabilizing composition for immobilized biomolecules
WO2022103871A1 (en) *	2020-11-10	2022-05-19	Wyomingv Immune, Inc.	Therapeutic compositions for the treatment of covid-19
CN114887047A (zh) *	2022-06-21	2022-08-12	苏州工业园区唯可达生物科技有限公司	基于ny-eso-1肿瘤抗原的疫苗及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4436558A1 (de) *	1994-10-13	1996-04-18	Vitorgan Arzneimittel Gmbh	Verfahren zur Herstellung von humanen Impfstoffen gegen allergieauslösende Substanzen
CA2205138A1 (en) *	1994-11-16	1996-05-23	Baxter International Inc.	Human antibodies to t-cell receptor peptides and methods for their preparation
DE19538641C2 (de) *	1995-10-05	2000-09-21	Privates Inst Bioserv Gmbh	Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
WO1998026086A1 (en) *	1996-12-11	1998-06-18	University Of Florida	Novel methods and compositions for treatment of autoimmune diseases
US7022036B2 (en) *	2003-05-21	2006-04-04	Prototoy Llc	Electronic throw-and-catch game

2001
- 2001-03-23 AT AT0047001A patent/AT410636B/de not_active IP Right Cessation
2002
- 2002-03-20 HU HU0303638A patent/HUP0303638A3/hu unknown
- 2002-03-20 US US10/472,876 patent/US20040191242A1/en not_active Abandoned
- 2002-03-20 SK SK1173-2003A patent/SK11732003A3/sk not_active Application Discontinuation
- 2002-03-20 MX MXPA03008587A patent/MXPA03008587A/es not_active Application Discontinuation
- 2002-03-20 CN CNA028088387A patent/CN1522155A/zh active Pending
- 2002-03-20 PL PL02363720A patent/PL363720A1/xx not_active Application Discontinuation
- 2002-03-20 WO PCT/AT2002/000091 patent/WO2002080966A2/de not_active Ceased
- 2002-03-20 EP EP02706509A patent/EP1370289A2/de not_active Withdrawn
- 2002-03-20 JP JP2002579005A patent/JP2004524369A/ja active Pending
- 2002-03-20 BR BR0208641-7A patent/BR0208641A/pt not_active Application Discontinuation
- 2002-03-20 CA CA002441499A patent/CA2441499A1/en not_active Abandoned
2003
- 2003-09-17 NO NO20034145A patent/NO20034145L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATA4702001A (de)	2002-11-15
AT410636B (de)	2003-06-25
NO20034145D0 (no)	2003-09-17
JP2004524369A (ja)	2004-08-12
BR0208641A (pt)	2004-03-09
WO2002080966A3 (de)	2003-09-12
WO2002080966A2 (de)	2002-10-17
MXPA03008587A (es)	2004-06-30
US20040191242A1 (en)	2004-09-30
CN1522155A (zh)	2004-08-18
HUP0303638A2 (hu)	2004-01-28
EP1370289A2 (de)	2003-12-17
PL363720A1 (en)	2004-11-29
SK11732003A3 (sk)	2004-03-02
HUP0303638A3 (en)	2004-10-28
CA2441499A1 (en)	2002-10-17
WO2002080966A8 (de)	2003-01-23

Legal Events

Date	Code	Title	Description
2006-10-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
CY2011001I1 (el)	2012-01-25	Εμβολια συνδυασμου για neisseria meningitidis
AU2002353378A8 (en)	2003-07-09	Vaccine for periodontal disease
NO20025576D0 (no)	2002-11-21	Fremgangsmåte for å tette en borebrönn
EP1461077A4 (en)	2006-01-25	MULTIPURPOSE IMMUNOGEN
NO20035208D0 (no)	2003-11-24	Nytt vaksine preparat
DK1427444T3 (da)	2013-11-04	West-nil-vaccine
HUP0402471A3 (en)	2005-04-28	Vaccine
DE60232264D1 (de)	2009-06-18	Suburethrale/zervikale ministütze
GB0407935D0 (en)	2004-05-12	Vaccine
EP1423141A4 (en)	2005-08-03	VACCINE
NO20033882D0 (no)	2003-09-02	Vaksine
GB0306611D0 (en)	2003-04-30	Novel vaccine
DE60201785D1 (de)	2004-12-09	Umreifungsmaschine
GB0121171D0 (en)	2001-10-24	Vaccine
DK1438336T3 (da)	2006-10-02	Gonadotropiner til follikeldannelse
DE60207081D1 (de)	2005-12-08	Hybridaufblasvorrichtung
IS6716A (is)	2003-02-13	Aðferðir við að framleiða sílostasól
NO20034145D0 (no)	2003-09-17	Fremgangsmåte til å produsere en vaksine
ITMI20021031A1 (it)	2003-11-14	Procedimento per preparare policarbonato-polioli
FI20010892L (fi)	2002-10-28	Menetelmä ksylitolin valmistamiseksi
DE60233230D1 (de)	2009-09-17	Höhenbildsyntheseverfahren
IS6928A (is)	2003-08-27	Aðferðir til að framleiða mirtasapínmilliefni
ZA200208395B (en)	2003-07-09	Surround for a grave.
FI20012299L (fi)	2003-05-24	Käyttäjätunnuksen muodostaminen
AU2002320807A1 (en)	2003-07-03	Vaccine for periodontal disease